How to Grow Your Clit: Hormones, Pumps & Surgery

Clitoral tissue can grow measurably through three main routes: androgen hormones (primarily testosterone), vacuum suction devices that increase blood flow, and surgical procedures that free or reconstruct tissue. The degree of change varies dramatically depending on the method, and each comes with a distinct set of trade-offs. What unites them is an underlying biological fact that makes all three possible: clitoral tissue is richly supplied with androgen receptors and responds to the same growth signals that drive penile development.

Why Clitoral Tissue Responds to Androgens

The clitoris and the penis develop from the same embryonic structure, the genital tubercle, and they share much of their cellular architecture. Research on fetal specimens has found dense zones of cell proliferation in both the developing clitoris and penis, particularly in the corporal body (the internal erectile tissue) and the glans.¹ Both tissues express androgen receptors, which means they are primed to respond when testosterone or its more potent derivative, dihydrotestosterone (DHT), shows up in the bloodstream.

This shared biology explains why conditions that raise androgen levels after birth reliably increase clitoral size. In congenital adrenal hyperplasia (CAH), an enzyme deficiency causes the adrenal glands to overproduce androgens, and affected girls develop noticeable clitoral enlargement as a direct result.² CAH is an uncontrolled hormonal environment, but it demonstrates the mechanism: give the tissue androgens, and it grows. That same principle is harnessed deliberately through testosterone therapy.

Testosterone Therapy

Testosterone is the most well-documented route to clitoral growth. It works for two overlapping but distinct groups of people: transgender men using testosterone as part of gender-affirming hormone therapy, and cisgender women using lower doses to treat sexual dysfunction. In both cases, the clitoris responds to circulating testosterone by increasing in size, though the timeline and degree depend on the dose and the individual.

For trans men on standard masculinizing doses, clitoral growth is one of the earlier and more consistent changes. Anecdotal reports and clinical observation suggest noticeable enlargement within the first few months, with continued growth over one to two years. The extent varies widely from person to person, which is a source of frustration for some and a pleasant surprise for others. Genetics, starting anatomy, and how efficiently your body converts testosterone into DHT all play a role.

At lower therapeutic doses, the clitoral changes are subtler but still measurable. A study of women with sexual dysfunction found that six months of testosterone therapy significantly increased blood flow to the clitoris, as measured by the peak speed of blood moving through the clitoral artery. The testosterone group showed a clear jump compared to women receiving estrogen alone or no hormones at all.³ Alongside the vascular changes, the same women reported higher scores across desire, arousal, lubrication, orgasm, and overall sexual satisfaction. The combination of testosterone with estrogen also improved these measures, suggesting the two hormones can complement each other.

Topical testosterone applied directly to the genital area can produce local effects as well. A study of women treated with topical testosterone for a vulvar skin condition found that serum testosterone levels rose in every patient, exceeding the normal female range in most of them. Within four weeks, four out of ten women showed signs of androgen effects including clitoral enlargement.⁴ That speed is worth noting: topical application can raise systemic hormone levels faster than many people expect, which brings us to side effects.

Side Effects and What to Watch For

Testosterone is not a targeted therapy. Even when the goal is localized clitoral growth, the hormone circulates throughout your body. At masculinizing doses, the full suite of androgenic changes comes along: body hair growth, voice deepening, skin oiliness, potential hair thinning at the temples, redistribution of body fat, and shifts in mood and libido. For trans men, these are the desired outcomes. For cisgender women seeking only clitoral enhancement, these are unwanted complications.

The topical testosterone study mentioned above illustrates the problem clearly. Although the cream was applied to the vulvar area, systemic testosterone levels spiked, and multiple women developed voice changes alongside the clitoral growth.⁴ Voice changes from testosterone can be permanent, even after stopping the hormone. This is one of the less reversible effects, and it catches some people off guard because topical application feels intuitively “local.”

If you are considering testosterone for clitoral growth specifically, regular blood work to monitor your hormone levels is important. Keeping testosterone in a controlled range reduces the chance of unwanted masculinization. The study on lower-dose therapy for sexual dysfunction found no significant changes in cholesterol, triglycerides, blood sugar, or insulin levels across the treatment groups, which is reassuring for metabolic safety at moderate doses.³ But metabolic safety and androgenic side effects are separate concerns, and the latter depends heavily on dose.

DHT creams, sometimes marketed online for genital growth, deserve special caution. DHT is a far more potent androgen than testosterone, and because it does not convert to estrogen the way testosterone can, its androgenic effects are amplified without the estrogenic buffer. Animal research has confirmed that DHT produces clitoral growth and tissue changes comparable to testosterone.⁵ The risk profile of unmonitored topical DHT use in humans is poorly studied, and compounded DHT products obtained without medical oversight carry additional quality-control concerns.

Vacuum Devices

If you want to increase clitoral engorgement and sensation without hormones, vacuum suction devices are the main non-pharmacological option. The best-studied example is the EROS Clitoral Therapy Device (EROS-CTD), a small battery-powered device that applies gentle suction to the clitoris. It was originally designed to treat female sexual dysfunction by enhancing blood flow to the clitoral tissue, and it received FDA clearance for that purpose.⁶

The mechanism is straightforward: the suction draws blood into the erectile tissue of the clitoris, producing temporary engorgement. Over repeated use, the increased blood flow may improve baseline arousal and sensitivity. The EROS device was tested in both healthy volunteers and women diagnosed with sexual dysfunction, assessing outcomes like genital sensation, lubrication, orgasm ability, and overall satisfaction. The appeal of this approach is that it avoids systemic hormone exposure entirely.

In practice, results from vacuum devices are temporary per session. The clitoris engorges during and shortly after use, but there is no robust evidence that vacuum suction produces permanent tissue growth the way hormones do. Some users report that consistent daily use over months leads to what feels like a lasting increase in baseline size, but this has not been confirmed in controlled studies. For people who want heightened sensation and temporary fullness without pills or creams, a vacuum device may be worth trying. For people seeking permanent size change, hormones or surgery are more reliable paths.

Topical Blood Flow Enhancers

Between hormones and vacuum devices sits another category: topical agents that increase genital blood flow without affecting androgen levels. Alprostadil, a synthetic form of prostaglandin E1 (a molecule your body naturally uses to regulate blood vessel dilation), has been studied for this purpose. When a small amount of alprostadil gel was applied to the clitoral and labial area, ultrasound measurements showed a significant increase in blood flow through the clitoral artery. All of the women in the study showed visible labial and clitoral engorgement, and most reported a pleasant warming sensation. No systemic side effects were detected.⁷

Alprostadil does not cause tissue growth in the way testosterone does. It works by temporarily dilating blood vessels, producing engorgement that fades after the drug wears off. Think of it as the clitoral equivalent of the vascular mechanism behind erection-enhancing drugs used for penile erectile dysfunction. Its potential role is more about improving sensation and arousal in the moment than about long-term anatomical change. Availability varies by country, and most formulations are compounded rather than commercially mass-produced, which means finding a reliable source requires some effort.

Surgical Approaches

Surgery to increase functional clitoral length is most established in the context of gender-affirming care for trans men. The procedure is called metoidioplasty, and it works by releasing the clitoral tissue from its surrounding ligaments and skin, effectively freeing the growth that testosterone has already produced and making more of it externally visible. Most people who undergo metoidioplasty have been on testosterone for at least one to two years beforehand, so the tissue has already enlarged before the surgeon begins.

A systematic review of metoidioplasty techniques identified four main approaches. The resulting neophallus length ranged from about 2 cm to 12 cm depending on the technique, with extensive metoidioplasty producing the largest outcomes and the labial ring flap technique producing the smallest.⁸ All four techniques included urethral lengthening, which allows the person to urinate while standing. The rate of successful standing urination varied by technique, with the lowest rate at about two-thirds of patients. Complication rates also depended on technique, with the Belgrade approach showing the lowest rates of fistula and urethral narrowing.

For people not seeking full masculinization, a simpler version exists: clitoral release without the urethral work or scrotoplasty. This is sometimes called a “simple release” or “clitoral unhooding,” depending on how much tissue is freed. The distinction between a modest surgical unhooding and a full metoidioplasty is a spectrum rather than a sharp line, and surgeons use different terminology, which can create confusion. The systematic review flagged this ambiguity, questioning whether “clitoral release” was just another name for metoidioplasty or a genuinely distinct procedure.

Preserving Sensation After Surgery

A legitimate concern with any clitoral surgery is whether sensation survives the procedure. The clitoris has an extraordinarily dense concentration of nerve endings, and damaging them during surgery can permanently reduce or eliminate sexual sensation. Modern surgical techniques are designed specifically to preserve the neurovascular bundle, the cluster of nerves and blood vessels that supply the clitoral glans.

A technique for clitoroplasty that preserves these neurovascular structures was described in a case series, and postoperative follow-up found no complaints of lost sensitivity or sexual dysfunction among the patients.⁹ That said, the evidence base here is small, and outcomes depend heavily on the individual surgeon’s skill and experience. If you are considering any procedure that involves the clitoral tissue, asking your surgeon specifically about their approach to nerve preservation is one of the most important questions you can raise.

Satisfaction After Gender-Affirming Genital Surgery

For trans men who pursue metoidioplasty, satisfaction data paint a mixed but largely positive picture. A study comparing outcomes in patients who had metoidioplasty with and without urethral lengthening found that about three-quarters were satisfied to very satisfied with their life overall after surgery. Roughly two-thirds were satisfied with the appearance of the neophallus, and a strong majority felt the surgery improved their sense of masculinity.¹⁰

The weakest area was sexual functioning: only about a third of participants reported being satisfied with the sexual function of the neophallus. That gap between appearance satisfaction and sexual function satisfaction is worth understanding before surgery. Metoidioplasty reliably creates a visible, masculinized genital appearance, but penetrative sexual function is limited by the modest size that even a well-performed metoidioplasty produces. People whose primary goal is penetrative function are sometimes counseled toward phalloplasty instead, which uses tissue grafts from other body sites to construct a larger phallus but comes with a substantially more complex surgical and recovery process.

Interestingly, the study found that satisfaction with the neophallus’s appearance and with urinary function were strong predictors of overall satisfaction, while complication rates and the number of follow-up surgeries were not.¹⁰ In other words, patients cared more about the end result than about the bumps along the way. Complications are common with metoidioplasty, but they tend to be surgically correctable and did not drive regret.

Combining Methods

In practice, many people who seek clitoral growth use more than one method. The most common combination is testosterone therapy followed by surgery, which is the standard pathway for trans men pursuing metoidioplasty. Testosterone does the biological work of enlarging the tissue over months or years, and surgery then maximizes the visible result by repositioning and releasing what has grown.

For cisgender women, a combination of low-dose topical testosterone with a vacuum device is sometimes used together, though this is more of a community practice than a clinically studied protocol. The logic is that testosterone promotes tissue growth while the vacuum device increases blood flow and engorgement, potentially supporting the growth process. Whether the two methods are genuinely synergistic or just additive is unknown, because no study has tested the combination against either method alone.

Alprostadil or other topical vasodilators could theoretically be layered with hormonal therapy as well, though again, combined protocols have not been studied. If you are experimenting with multiple approaches, tracking your hormone levels and any side effects becomes even more important, since interactions between therapies can be unpredictable.

The Spotted Hyena and What It Reveals About Clitoral Biology

One of the most striking examples of androgen-driven clitoral development in nature comes from the spotted hyena. Female spotted hyenas lack an external vulva entirely. Instead, they urinate, mate, and give birth through an elongated clitoris that closely resembles a penis, complete with erectile tissue and a pseudo-scrotum formed from fused labial folds.¹¹ This anatomy develops under the influence of unusually high androgen exposure during fetal life, and it persists into adulthood.

Hyena biology is not a roadmap for human anatomy, but it offers a vivid illustration of how powerful androgens can be in shaping genital tissue. It also challenges the idea that clitoral and penile tissue are locked into fixed size categories by sex. Given the right hormonal environment, the same underlying tissue can develop along a wide spectrum. For humans exploring clitoral growth, the lesson is less about mimicking hyenas and more about understanding that the biological capacity for change is genuinely there: the tissue is responsive, the receptors are present, and the growth signals work. The practical question is always how to use that biology safely and with realistic expectations about what each method can achieve.